AZR-MD-001

N/A

Report date: 2026/03/09 20:02:04
NME

Base Information

Drug NameAZR-MD-001
Drug Alias NameAZR-MD-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteolysis
TargetsNot applicable
Therapy Area/IndicationsDry Eye SyndromesMeibomian Gland DysfunctionXerophthalmia +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[4
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAzura Ophthalmics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAzura Ophthalmics Ltd
Inactive CompaniesN/A
Active IndicationsDry Eye SyndromesMeibomian Gland DysfunctionXerophthalmia
Inactive IndicationsEye Diseases

Other Information

ATC CodeN/A
Related LinksN/A